hims novo nordisk - Search News

News

Novo Nordisk, Investor Attention

Reuters on MSN · 2d

As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims?

In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims & Hers .

TipRanks on MSN · 1d

Novo Nordisk’s Promising Study on Heart Failure Treatment: What Investors Need to Know

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting an open-label extension

Zacks.com on MSN · 1d

Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

6hon MSN

Hims & Hers CEO sells $33 million in stock after a massive rally

Shares of Hims & Hers Health Inc. have roughly doubled over the past year — and Chief Executive Andrew Dudum cashed in on the ...

7d

Hims & Hers: Still Growing After Breakup With Novo Nordisk

Hims & Hers is a top telehealth stock with strong revenue growth, innovative offerings, and long-term potential. Click here ...

Novo Nordisk's Legal Blitz: The Missing Piece in the Battle Against Compounded Weight-Loss Drugs

Novo Nordisk's legal actions against U.S. pharmacies over compounded copies of its drug Wegovy exclude Hims & Hers, a ...

8don MSN

Hims & Hers stock slides 5% after second quarter revenue misses forecasts

Hims & Hers Health stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of ...

1don MSN

Hims & Hers Health CEO discloses sale of over $33M worth of company stock

Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

3don MSN

Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills?

Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending ...

7don MSN

Novo Nordisk expands lawsuits against weight-loss drug compounders

Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of ...

13don MSN

Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?

Danish leader will face a challenging landscape among competitors ...

11d

Sell HIMS Stock Ahead of Its Earnings?

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an ...

26d

Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results